CX Institutional’s Medpace MEDP Stock Holding History

CX Institutional’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.57M	Sell	2,962 -1,390	-32%	-$642K	0.05%	282
2026 Q1	$2.09M	Sell	4,352 -91	-2%	-$46.6K	0.06%	246
2025 Q4	$2.5M	Hold	4,443	–	–	0.07%	182
2025 Q3	$2.28M	Hold	4,443	–	–	0.07%	195
2025 Q2	$1.39M	Buy	+4,443	New	+$1.33M	0.05%	225
2025 Q1	–	Sell	-833	Closed	-$277K	–	1206
2024 Q4	$277K	Hold	833	–	–	0.01%	458
2024 Q3	$278K	Hold	833	–	–	0.01%	479
2024 Q2	$343K	Buy	+833	New	+$330K	0.02%	429

Other funds holding MEDP

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Asio Capital Lexington, Kentucky $781M AUM 26.78% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CX Institutional's MEDP Position: Q2 2026 in Review

CX Institutional reduced its Medpace (MEDP) stake by 32% in Q2 2026, selling an estimated $642K and leaving 2,962 shares worth $1.57M. The position accounts for 0.05% of the portfolio, ranked #282.

CX Institutional first reported a position in MEDP in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.5M in Q4 2025. 75 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

CX Institutional held 2,962 shares of Medpace worth $1.57M as of Q2 2026.
CX Institutional sold 1,390 Medpace shares in Q2 2026, an estimated $642K.
Medpace made up 0.05% of CX Institutional's portfolio in Q2 2026, its #282 holding.
CX Institutional first reported a position in Medpace in Q2 2024 and has held it in 8 quarters since.
CX Institutional's Medpace position peaked at $2.5M in Q4 2025.
75 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.